Login to Your Account



Pharming Gets Up To $30M Via Paul Royalty Fund Deal

By Cormac Sheridan


Wednesday, February 8, 2006
Just one week after taking in €17.1 million (US$20.6 million) in a private placing, Pharming Group NV banked another $18.5 million as part of a royalty agreement with Paul Royalty Fund that could be worth up to $30 million in total. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription